| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
15,730,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Scopus BioPharma is a clinical-stage biopharmaceutical company developing therapeutics targeting diseases. Co. has launched its Duet BioTherapeutics, Inc., which integrates the management and clinical development of immunotherapy (the Duet Platform). Co. has several licenses, a research agreement and a clinical research support agreement relating to the Duet Platform with City of Hope. The Duet Platform is comprised of complementary bifunctional oligonucleotides that each consist of a toll-like receptor 9 agonist linked with a signal transducer and activator of transcription 3 inhibitor: RNA silencing, CpG-STAT3siRNA; antisense, CpG-STAT3ASO; and DNA-binding inhibitor, CpG-STAT3decoy.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Greenspan Ira Scott |
Executive Committee Chairman |
• • • |
2021-08-27 |
4 |
B |
$4.98 |
$3,934 |
I/I |
790 |
14,640 |
2.56 |
- |
|
| Greenspan Ira Scott |
Executive Committee Chairman |
• • • |
2021-08-27 |
4 |
B |
$4.92 |
$541 |
D/D |
110 |
82,450 |
3.15 |
- |
|
| Lamstein Joshua R |
Chairman |
• • • |
2021-08-27 |
4 |
B |
$5.00 |
$1,000 |
D/D |
200 |
119,997 |
3.15 |
- |
|
| Lamstein Joshua R |
Chairman |
• • • |
2021-08-26 |
4 |
B |
$4.90 |
$980 |
D/D |
200 |
119,797 |
3.15 |
- |
|
| Greenspan Ira Scott |
Executive Committee Chairman |
• • • |
2021-08-24 |
4 |
B |
$4.65 |
$233 |
D/D |
50 |
82,340 |
3.15 |
- |
|
| Greenspan Ira Scott |
Executive Committee Chairman |
• • • |
2021-08-23 |
4 |
B |
$4.41 |
$2,205 |
D/D |
500 |
82,290 |
3.15 |
- |
|
| Greenspan Ira Scott |
Executive Committee Chairman |
• • – |
2021-08-20 |
4 |
B |
$4.23 |
$1,692 |
D/D |
400 |
81,790 |
2.73 |
- |
|
| Lamstein Joshua R |
Chairman |
• • – |
2021-08-19 |
4 |
B |
$4.04 |
$3,232 |
D/D |
800 |
119,597 |
2.73 |
- |
|
| Greenspan Ira Scott |
Executive Committee Chairman |
• • – |
2021-08-19 |
4 |
B |
$4.04 |
$8,080 |
I/I |
2,000 |
13,850 |
2.58 |
- |
|
| Greenspan Ira Scott |
Executive Committee Chairman |
• • – |
2021-08-18 |
4 |
B |
$4.27 |
$4,270 |
I/I |
1,000 |
11,850 |
2.58 |
- |
|
| Greenspan Ira Scott |
Executive Committee Chairman |
• • – |
2021-08-17 |
4 |
B |
$4.13 |
$4,130 |
I/I |
1,000 |
10,850 |
2.58 |
- |
|
| Greenspan Ira Scott |
Executive Committee Chairman |
• • – |
2021-07-27 |
4 |
B |
$4.54 |
$908 |
D/D |
200 |
81,390 |
2.73 |
- |
|
| Greenspan Ira Scott |
Executive Committee Chairman |
• • – |
2021-07-26 |
4 |
B |
$4.76 |
$1,904 |
D/D |
400 |
81,190 |
2.73 |
- |
|
| Greenspan Ira Scott |
Executive Committee Chairman |
• • – |
2021-07-26 |
4 |
B |
$4.78 |
$4,780 |
I/I |
1,000 |
9,850 |
2.58 |
- |
|
| Lamstein Joshua R |
Chairman |
• • – |
2021-07-23 |
4 |
B |
$4.71 |
$7,065 |
D/D |
1,500 |
118,797 |
2.81 |
- |
|
| Greenspan Ira Scott |
Executive Committee Chairman |
• • – |
2021-07-23 |
4 |
B |
$4.77 |
$5,247 |
I/I |
1,100 |
8,850 |
2.58 |
- |
|
| Horsager Alan M |
See RemarksOfficer |
• – – |
2021-06-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
118,200 |
|
- |
|
| Hopper Paul |
Director |
– • – |
2021-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,333 |
0 |
|
- |
|
| Hopper Paul |
Director |
– • – |
2021-06-01 |
4 |
A |
$0.00 |
$0 |
I/I |
700,000 |
0 |
|
- |
|
| Greenspan Ira Scott |
Executive Committee Chairman |
• • – |
2021-02-25 |
4 |
B |
$9.01 |
$7,208 |
I/I |
800 |
7,750 |
2.58 |
- |
|
| Gibson Robert J |
Vice Chairman |
• • – |
2021-02-25 |
4 |
B |
$9.29 |
$1,394 |
D/D |
150 |
300 |
2.73 |
- |
|
| Greenspan Ira Scott |
Executive Committee Chairman |
• • – |
2021-02-24 |
4 |
B |
$9.45 |
$2,835 |
I/I |
300 |
6,950 |
2.58 |
- |
|
| Greenspan Ira Scott |
Executive Committee Chairman |
• • – |
2021-02-24 |
4 |
B |
$9.48 |
$1,090 |
D/D |
115 |
80,790 |
2.73 |
- |
|
| Gibson Robert J |
Vice Chairman |
• • – |
2021-02-24 |
4 |
B |
$9.46 |
$1,419 |
D/D |
150 |
150 |
2.73 |
- |
|
| Greenspan Ira Scott |
Executive Committee Chairman |
• • – |
2021-02-23 |
4 |
B |
$9.66 |
$12,558 |
I/I |
1,300 |
6,650 |
2.58 |
- |
|
42 Records found
|
|
Page 1 of 2 |
|
|
